Clinical features and treatment results in preterm infants with intracardiac thrombus.

The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Mustafa KaraNaci Ceviz

Abstract

Thrombus incidence is higher among neonates, especially in preterm infants, due to the associated additional risk factors. The medical recordings of premature infants who had been diagnosed as having intracardiac thrombus between January 2016 and January 2019 were evaluated retrospectively. We use recombinant tissue plasminogen activator when the thrombus is relatively large compared to left atrium, pedunculated, mobile, or snake shaped. A total of 13 premature patients were diagnosed as having intracardiac thrombus during the 3-year period. All were diagnosed during echocardiographic studies. Low molecular weight heparin was administered in four patients. In three, recombinant tissue plasminogen activator was started with low dose (0.01 mg/kg/h) and increased gradually to 0.06 mg/kg/h. In three, recombinant tissue plasminogen activators were started with standard dose (0.5 mg/kg/h). In one recombinant tissue, plasminogen activator was started with low dose (0.01 mg/kg/h) and increased to standard dose. Two patients died before treatment, three patients died during treatment, follow-up was not available for two patients, and thrombus completely resolved in six patients. In preterm babies with risk factors, intracardiac thrombus...Continue Reading

References

Sep 4, 1997·The New England Journal of Medicine·J I Weitz
Jun 23, 2001·Archives of Disease in Childhood. Fetal and Neonatal Edition·J HartmannK H Hennecke
Jan 5, 2002·Paediatric Drugs·P C RimensbergerM Beghetti
Apr 17, 2002·European Journal of Pediatrics·Manuela Albisetti, Maureen Andrew
May 22, 2003·Journal of Pediatric Hematology/oncology·Michael WangUNKNOWN Pediatric Coagulation Consortium
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·G YoungD J Nugent
Apr 23, 2004·Journal of Thrombosis and Haemostasis : JTH·J Harenberg
Jan 1, 2008·Vascular Health and Risk Management·Alex VeldmanIna Michel-Behnke
Oct 8, 2009·British Journal of Haematology·Michael D Williams
Mar 23, 2010·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Janet Yk YangAnthony Kc Chan
Jun 5, 2010·Stroke; a Journal of Cerebral Circulation·Florieke J BerfeloTimo R de Haan
Sep 6, 2011·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·C MichotS Dauger
May 2, 2013·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Janet Y K YangTapas Mondal
Jan 31, 2014·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Christina K ParkUNKNOWN Thrombosis and Hemostasis in Newborns (THiN) Group
Jan 21, 2016·The Journal of Pediatrics·Paola SaraccoUNKNOWN Neonatal Working Group of the Registro Italiano Trombosi Infantili (RITI)
Oct 25, 2016·Seminars in Thrombosis and Hemostasis·Santosh S HanmodMeera Chitlur
May 12, 2018·Journal of Pediatric Hematology/oncology·Sevim UnalNeşe Yarali
Aug 8, 2018·Türk Pediatri Arşivi·Tiraje Celkan, Gürcan Dikme

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.